Skip to main content
Midas Edge

agilon health, inc.

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

AGL$113.39-0.3%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

ExhibitNumberDescription
3.1Amended and Restated By-laws of agilon health, inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed August 4, 2025).
3.2Certificate of Amendment to the Amended and Restated Certificate of Incorporation of agilon health, inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed March 30, 2026).
10.1Employment Agreement, dated as of March 27, 2026, by and between Denise Zamore and agilon health, inc. (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q filed May 6, 2026).†
10.2Employment Agreement, dated as of April 24, 2026, by and between Tim O’Rourke and agilon health, inc. (incorporated by reference to Exhibit 10.4 to the Quarterly Report on Form 10-Q filed May 6, 2026).†
10.3Employee Restricted Stock Unit Agreement, effective as of May 7, 2026, by and between Tim O’Rourke and agilon health, inc. (incorporated by reference to Exhibit 10.4 to the Quarterly Report on Form 10-Q filed May 6, 2026).†
10.4Employee Restricted Performance Stock Unit Agreement, effective as of May 7, 2026, by and between Tim O’Rourke and agilon health, inc. (incorporated by reference to Exhibit 10.6 to the Quarterly Report on Form 10-Q filed May 6, 2026).†
10.5Severance Agreement and General Release, dated as of July 17, 2026, by and between agilon health, inc. and Girish Venkatachaliah (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed July 22, 2026).†*
10.6Fourth Amendment to Credit Agreement, dated as of April 9, 2026, among agilon health, inc., agilon health management, inc. (f/k/a agilon health, inc.), Agilon Health Intermediate Holdings, Inc., the Subsidiary Guarantors party thereto, the Lenders and Issuers from time to time party thereto and J.P. Morgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.9 to the Quarterly Report on Form 10-Q filed May 6, 2026).
ExhibitNumberDescription
31.1Certification by Timothy O’Rourke, agilon’s Principal Executive Officer, Pursuant to Securities Exchange Act Rule 13a-14(a).*
31.2Certification by Jeffrey Schwaneke, agilon’s Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a-14(a).*
32.1Certification by Timothy O’Rourke, agilon’s Principal Executive Officer, Pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.**
32.2Certification by Jeffrey Schwaneke, agilon’s Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350.**
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.*
101.SCHInline XBRL Taxonomy Extension Schema Document.*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*
104Cover Page Interactive Data File (embedded within the Inline XBRL document).*

*Filed herewith.

**Furnished herewith.

† Identifies each management contract or compensatory plan or arrangement.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.